06/19/2026
Lots of misinformation... I've euthanized 2 very young dogs recently for Lyme disease leading to kidney failure. Very very sad ! Please don't believe everything you read! Info on Bravecto Quantum our newest flea/tick preventive!
For roughly three decades, every new flea and tick preventative has been met with the same cycle: Advantage was going to kill dogs. Then Frontline. Then Trifexis. Then Comfortis, Sentinel, NexGard, and Bravecto. Each one declared poison.
Each one the end of our pets as we know it. And yet, here we are.
Right on schedule, Bravecto Quantum has taken its place in the rotation — referred to in this post as "Flea Injection."
Here are the actual facts:
1. "Poison injection" is a mischaracterization.
Fluralaner (the active ingredient) is an insecticide — it works by targeting the nervous systems of fleas and ticks, not mammals. Isoxazoline products are commonly used and safe for most dogs and cats. Calling it a poison injection for dogs is misleading.
2. The FDA approval process is rigorous.
Bravecto Quantum underwent extensive safety testing, including safety demonstration at 5 times the recommended dose given every 4 months for a total of 6 doses. That's not something a dangerous drug passes.( 6 years worth of medication was administered)
3. The seizure risk is real but rare and already disclosed.
In the U.S. field study, only 0.9% of dogs (2 out of 225) experienced seizures — a rate consistent with what's reported in the general dog population. The neurological warning is on the label precisely because transparency is required. Veterinarians are already instructed to use it with caution in dogs with a prior history of seizures or neurologic disorders.
4. The "irreversible" framing is exaggerated.
A veterinary dermatologist reviewing the safety data concluded that most adverse effects are likely to be self-limiting and of short duration. The long duration of the drug is a legitimate discussion point — but "watch and hope" is not the clinical picture.
5. The post discourages the conversation that should actually happen.
No one is saying every dog should get this. Pet owners should consult with their veterinarian to determine whether an isoxazoline product is appropriate for their specific pet. That's the right approach — not blanket social media fear-mongering.
Bottom line: The neurological risks are real and are transparently disclosed on the label. This drug isn't appropriate for every dog. But replacing nuance with alarm — and discouraging veterinary consultation — is what actually puts dogs at risk.
P.S. — For those keeping score, Bravecto Quantum isn't exactly fresh off the assembly line. It was first approved in Australia and New Zealand in 2023, then the European Union in 2024, before finally reaching the U.S. in July 2025. It is now approved in over 50 countries worldwide. If this injection were the mass canine catastrophe this post suggests, we'd likely have heard about it from the other side of the world by now.
We are a small animal clinic devoted to providing the highest quality care for your family pets!
